Medistep Healthcare IPO Allotment in Spotlight Today: How to Check Status, GMP, and Listing Date

Medistep Healthcare’s initial public offering (IPO) has garnered significant investor interest and is now entering a crucial phase as the allotment process is finalized on August 13, 2025. Following an overwhelmingly oversubscribed issue, investors are eagerly awaiting the allotment results, as well as updates on the grey market premium (GMP) and expected listing date. Here's a detailed breakdown to help investors navigate the next steps.

 

Key Highlights of Medistep Healthcare IPO:

 

Issue Size and Pricing: The IPO is a fresh issue of approximately 37.44 lakh equity shares aimed at raising ₹16.10 crore. The fixed price was set at ₹43 per share, with a lot size of 3,000 shares.

 

Subscription Performance: The IPO was massively oversubscribed, receiving bids for nearly 13.58 crore shares against an offer of 35.55 lakh shares, resulting in an overall subscription of 382.14 times. Retail investors led the demand by subscribing 461.11 times, while non-institutional investors (NIIs) subscribed 289.15 times.

 

Allotment Date and Status: The allotment is scheduled to be finalized on August 13, 2025. Investors can check their allotment status online via registrars’ websites like Cameo Corporate Services Limited or on NSE SME exchange portals. The process involves entering details such as PAN number, application number, or demat account to view the allocation results.

 

Medistep Healthcare IPO Grey Market Premium (GMP):

As of August 13, 2025, the grey market premium for Medistep Healthcare IPO shares stands at around ₹13 above the issue price, indicating robust aftermarket demand and positive investor sentiment. This premium suggests the expected listing price could hover near ₹56, translating to potential listing gains of nearly 30%.

 

GMP is a market-based indicator of the IPO’s popularity but should be viewed cautiously as it is unofficial and subject to fluctuations based on market conditions.

 

Listing Date and Post-Allotment Timeline:

 

The IPO shares are expected to be credited to investors’ demat accounts by August 14, 2025, with refunds initiated for unsuccessful applicants on the same date.

 

Medistep Healthcare’s shares are scheduled to be listed on the NSE SME platform on August 18, 2025, allowing investors to trade the company’s stock publicly.

 

The SME IPO follows the T+3 settlement rule, meaning the listing occurs three trading days after share allotment finalization.

 

How to Check Medistep Healthcare IPO Allotment Status Online:

Investor Takeaways and Outlook:

 

Despite the small issue size, the overwhelming subscription reflects strong market confidence in Medistep Healthcare’s business prospects, diversified product portfolio, and management.

 

The company operates across pharmaceutical manufacturing, trading of healthcare products, and niche segments like feminine hygiene and nutraceuticals, positioning it for growth in expanding healthcare markets.

 

Listing gains are anticipated due to high demand and positive GMP, but investors should consider long-term fundamentals beyond initial aftermarket interest.

 

Post-listing, careful monitoring of company performance, sector developments, and stock price trends will be crucial for sustained investment returns.

 

In summary, August 13, 2025, marks a pivotal moment as Medistep Healthcare’s IPO allotment is finalized following an impressive subscription. With a healthy grey market premium signaling strong demand and the listing set for August 18, investors can soon participate in trading this promising healthcare entity on the NSE SME platform. Checking the allotment status promptly via official channels will determine successful applications and prepare shareholders for upcoming market activity.

 

Source: Angel One, IPO Watch, Univest, Zerodha, NDTV Profit, 5Paisa, NSE SME